Treatment of central serous chorioretinopathy with beta-blocker metipranolol

Biomedical Papers

Volumn 159, Issue 1, 2015, Pages 120-123

  Chrapek, Oldrich ^a   Jirkova, Barbora ^a   Kandrnal, Vít ^b   Rehak, Jiri ^a   Sin, Martin ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Betablocker; Central serous chorioretinopathy; Metipranolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METIPRANOLOL;

ADULT; CENTRAL SEROUS CHORIORETINOPATHY; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; FOLLOW UP; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA LUTEA; TREATMENT OUTCOME; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; CENTRAL SEROUS CHORIORETINOPATHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULA LUTEA; METIPRANOLOL; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84924495693     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2013.015     Document Type: Article

References (17)

1. Von Graefe A. Über centrale recidivierende Retinitis. Graefes Arch Clin Exp Ophthalmol 1866;12:211-5.
2. Fabianova J, Porubska M, Cepilova Z. Centralna serozna chorio- retinopatia- novy model etiopatogenezy. Cesk Slov Oftalmol 1998;54:405-88.
3. Kondrova J. Centralni serozni chorioretinopatie. Cesk Slov Oftalmol 1995;51:304-9.
4. Romani A, Bartolomei MP, Puccioni M, Malfatti P. Alterazione del senzo cromatico consegunte a corioretinopatia sierosa centrale. Ann Oftal Clin Oculist 1987;113:759-63.
5. Brancato R, Bandello F. Central serous retinopathy (atypical forms). Bull Soc Belge Ophtalmol 1991;240:119-31.
6. Harada T, Harada K. Six cases of central serous choroidopathy induced by systemic cortocosteroid therapy. Doc Ophthalmol 1985;60:37-44.
7. Bandello F, Incorvaia C, Rosa N, Parmeggiani F, Costagliola C, Sebastini A. Bilateral central serous chorioretinopathy in a patient treated with systemic cortico-steroids for non-Hodgkin lymphoma. Eur J Ophthalmol 2002;12:123-6.
8. Avci R, Deutman AF. Die Behandlung der zentralen serösen Choroidopathie mit dem Betarezeptorenblocker Metoprolol. Klin Monbl Augenheilkd 1993;202:199-205.
9. Fabianova J, Porubska M, Cepilova Z. Centralna serozna chorioreti- nopatia- liecba betablokatormi. Cesk Slov Oftalmol 1998;54:401-4.
10. Potts AM. An hypothesis on macular disease. Trans Am Acad Ophthalmol Otolaryngol 1966;70:1058-62.
11. Miki T, Sunada I, Hagaki T. Studies on chorioretinitis induced in rabits by stress (Repeated administration of epinefrine). Acta Soc Ophthalmol Jpn 1972;76:1045-57.
12. Nagayoski K. Experimental study of chorioretinopathy by in- travenous injection of adrenaline. Acta Soc Ophthalmol Jpn 1971;75:1720-7.
13. Yasuzumi T, Miki, T, Sugimoto K. Electron microscopic studies of epinefrine choroiditis in rabbits. I. pigment epithelium and Bruch's membrane in the healed stage. Acta Soc Ophthalmol Jpn 1974;78:588-98.
14. Yannuzzi LA. Type- A behaviour and central serous chorioretinopa- thy. Retina 1987;7:111-30
15. Koh SWM, Chader GJ. Retinal pigment epithelium in culture dem- ostrates a distinct beta- adrenergic receptor. Exp Eye Res 1984;38:7-13.
16. Spitznas M. Pathogenesis of central serous retinopathy: a new work- ing hypothesis. Graefes Arch Clin Exp Ophthalmol 1986;224:321-4.
17. Chrapek O, Spackova K, Rehak J. Lecba centralni serozni chorioreti-nopatie betablokatory. Cesk Slov Oftalmol 2002;58:382-6.